Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinosarcoma × Trabectedin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 14 Ovarian Neoplasms 6 Liposarcoma 5 Leiomyosarcoma 5 Neoplasms 4 Liposarcoma, Myxoid 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Prostatic Neoplasms 2 Osteosarcoma 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Ichthyosis, X-Linked 2 Endometrial Neoplasms 2 Breast Neoplasms 2 Uterine Neoplasms 1 Solitary Fibrous Tumors 1 Soft Tissue Neoplasms 1 Sarcoma, Synovial 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Alveolar Soft Part 1 Recurrent High Grade Meningioma 1 Pancreatic Neoplasms 1 Ovarian Diseases 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms by Site 1 Mesothelioma 1 Malignant mesenchymal tumor 1 Leiomyosarcoma Uterus 1

Interventions

Nivolumab 5 Paclitaxel 3 olaparib 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 rucaparib 1 pazopanib 1 pamiparib 1 durvalumab 1 ceralasertib 1 cediranib 1 cabozantinib 1 apatinib 1 Trabectedin 1 Ipilimumab 1 Gemcitabine 1 Cisplatin 1 Carboplatin 1 CTLA-4 Antigen 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02993705 2021-08-25

MITO 26

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 2 Completed

Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡